River BioMedics
Enschede
About River BioMedics
River BioMedics is a biotech company that aims to develop human 3D in vitro 3D human heart tissue for pre-clinical drug testing. Currently pharmaceutical companies spend a billion dollar figure on the development of a new drug entity, with a 90% chance of it failing to reach the market. The most common reason for failure during this developmental stage is drug induced cardiac toxicity. To solve this issue we develop 3D cardiac tissues, resembling the working human heart, for advanced drug discovery and toxicity screening using a multidisciplinary human stem cell-based approach.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $2.0M
- Funding stage: Seed
- Last round: Seed (Jan 2022)
- Website: riverbiomedics.com
- Phone: +31623609933
Industries & Categories
Biotechnology, Health Care, Hospital, Medical, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/river-biomedics-17466 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.